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Abstract
Nasopharyngeal carcinoma (NPC) is a malignancy of epithelial origin. The etiology of NPC is complex and includes multiple
genetic and environmental factors. We employed case-control analysis to study the association of chromosome 6p regions
with NPC. In total, 360 subjects and 360 healthy controls were included, and 233 single nucleotide polymorphisms (SNPs) on
6p were examined. Significant single-marker associations were found for SNPs rs2267633 (p=4.49610
25), rs2076483 (most
significant, p=3.36610
25), and rs29230 (p=1.43610
24). The highly associated genes were the gamma-amino butyric acid B
receptor 1 (GABBR1), human leukocyte antigen (HLA-A), and HLA complex group 9 (HCG9). Haplotypic associations were
found for haplotypes AAA (located within GABBR1, p-value =6.46610
25) and TT (located within HLA-A, p=0.0014). Further
investigation of the homozygous genotype frequencies between cases and controls suggested that micro-deletion regions
occur in GABBR1 and neural precursor cell expressed developmentally down-regulated 9 (NEDD9). Quantitative real-time
polymerase chain reaction (qPCR) using 11 pairs of NPC biopsy samples confirmed the significant decline in GABBR1 and
NEDD9 mRNA expression in the cancer tissues compared to the adjacent non-tumor tissue (p,0.05). Our study
demonstrates that multiple chromosome 6p susceptibility loci contribute to the risk of NPC, possibly though GABBR1 and
NEDD9 loss of function.
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Introduction
Nasopharyngeal carcinoma (NPC) is an epithelial-originated
malignancy. Its etiology is complex and comprises multiple genetic
and environmental factors. Epstein-Barr virus (EBV) infection [1],
unhealthy lifestyle such as consumption of pickled food [2], and
exposure to noxious inhalants [3] can predispose to NPC
development. The incidence of NPC shows distinct geographical
and ethnical differences. The susceptibility of NPC is nearly 100-
foldhigherinSoutheastAsia,particularlyinthe Chineseprovinceof
Guangdong, than in most countries of predominantly European
descent. Thus, NPC is also referred to as the Cantonese cancer
because itsincidencerangesfrom 10–50casesper100,000 peoplein
this region [4,5]. This NPC epidemic also shows familial
aggregation; it was reported that the risk of NPC susceptibility is
9.31 times higher in first-degree relatives of the patient than in first-
degree relatives of the spouse [6].
Genetic efforts to identify NPC susceptibility genes have employed
both linkage studies and the candidate-gene–based approach [7].
Several chromosome regions, such as 3p12.3-14.2, 3q26.2-26.32 [8],
3p21.3-1-21.2 [9], and 6p21.3 [10], have been linked to NPC
susceptibility and numerous disease-susceptible genes or loci have
been associated with NPC. The chr6 super loci containing the human
leukocyte antigen (HLA) system has been linked to the pathogenesis
of NPC [10,11,12], as have the cell cycle regulation genes cyclin D1
(CCND1) [13], p53 [14], and carcinogen-metabolism gene glutathione
S-transferase M1 (GSTM1) [15]. More recently, two different groups
utilized a genome-wide association study (GWAS) to scan the whole
human genome for disease susceptibility loci [10,12], and showed an
elevated genetic susceptibility in southern Chinese.
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14562The linkage of NPC to 6p21.3 [11] provides a genetic basis for a
more thorough linkage analysis for disease susceptible loci in
different populations. We began the study of NPC-associated
genetic markers by using case-control analysis. The top 15 NPC
genes within the linkage region were chosen from PubMed
references (Table S2), and then tag single nucleotide polymor-
phisms (tag SNPs) within the genes were selected from the
HapMap CHB database. In total, 233 tag SNPs ranging from
6095364–30048467 on chromosome 6p were selected to test
whether the SNPs were associated with NPC in southern Chinese.
Materials and Methods
Study subjects and NPC biopsy samples
In total, 360 subjects of southern Chinese descent from
Guangdong were pathologically diagnosed with NPC. Approvals
for this study were obtained from the Hospital Institutional Review
Board of the University of Hong Kong and Sun Yat-sen University
Cancer Centre. A written informed consent was obtained from all
participants. In the disease group, 71.8% were males, and 28.9%
were females. The mean age of patients was 46.4611.2 years
(ranging from 16–75 years old). The healthy controls comprising
360 subjects were provided through the degenerate disc disease
(DDD) study from southern Chinese (Area of Excellence Project
from the University of Hong Kong). The controls were matched to
the NPC cases by age (65 years), sex, geographic region, and
ethnicity. In the control group, 65.6% were females, and 34.4%
were males. The mean age was 41.468.9 years (ranging from 14–
63 years old).
SNP selection
The SNPs in this study were selected based on the candidate
gene in combination with PLINK and Haploview tag SNP
selection algorithms. We used DDD study subjects as controls; the
DDD study already has the whole genome scan data with 17,313
SNPs genotyped on chromosome 6. For quality control, the
genotype missingness frequency (GENO) was set to GENO ,0.05
and the minor allele frequency (MAF) to MAF .0.05 when we
selected SNPs from the DDD study. After frequency and genotype
pruning, 11,772 SNPs were left. Focusing solely on the genes
located in the candidate region identified by the meta-analysis of
the top candidate genes (PLINK filter from chromosome 6: 6–31
Mb), 2,730 SNPs remained, and among these only tag SNPs were
selected using the HapMap tag SNP picking tool Tagger. The R-
square cut-off value was set to 0.8. Only 233 tag SNPs were
ultimately selected for genotyping.
SequenomH (San Diego, CA) SNP genotyping
The MassARRAY Assay Design software (Sequenom) was used
to design amplification and allele-specific extension primers for
uniplex or multiplexed assays. Polymerase chain reactions (PCR)
were set up in 384-well plates with 6 uL total volume per reaction;
the reaction mix contained 5 ng genomic DNA, 0.3 pmol each of
the specific forward and reverse primers, 200 mM dNTP,
3.25 mM MgCl2, and 0.2 units of HotStar Taq polymerase
(5 U/mL, Qiagen, Valencia, CA). The PCR conditions were as
follows: initial denaturation at 95uC for 15 min, 45 cycles of 95uC
for 20 s, 56uC for 30 s, and 72uC for 1 min, followed by final
elongation at 72uC for 3 min. The extension primer was designed
to hybridize to the amplicon located near the SNP site for the
extension of a single base or a few bases depending on the
genotype of the allele. Polymerase chain reactions, treatment of
PCR products with alkaline phosphatase, and mass extension
reactions were all performed according to the manufacturer’s
protocol (Sequenom). The final base-extension products were
desalted using SpectroClean resin (Sequenom) mixed with 3-
hydroxypicolinic acid, and analyzed using a modified Brucker
Autoflex MALDI-TOF mass spectrometer (Brucker, Billerica,
MA).
ABI TaqmanH SNP genotyping
The genotyping of 12 significant SNPs from a Taiwanese group
was conducted using ABI Taqman (Carlsbad, CA) SNP
genotyping assays. Human pre-designed Taqman probes were
provided by the Taiwanese group (led by Prof. Chang). The assays
were performed by ABI Prism 7900HT Sequence Detection
System using the 384-well block at the Genome Research Centre,
University of Hong Kong. Real-time data were analyzed using the
SDS 2.3 application provided by ABI. Genotyping quality control
was achieved through cross-plate controls and duplicates. Taqman
SNP genotyping quality control was assessed by the service
provider and checked manually. The average call rate per sample
was .98%, whereas the average call rate per SNP was .95%.
NPC tissues
To examine candidate gene expression, 20 primary NPC
biopsies and adjacent normal tissue at the resection margins were
collected immediately after the surgical resection at Queen Mary
Hospital in Hong Kong. Of these samples, 11 provided enough
high quality RNA for further investigation.
NPC cell lines
The three NPC cell lines used in this study, CNE2 [16], SUNE1
[17], and C666-1 [18], were maintained in RPMI-1640 medium
(Sigma, St. Louis, MO) and supplemented with 10% fetal bovine
serum. An immortalized nasopharyngeal epithelial cell line, NP69
[19], was also cultured.
Total RNA extraction and reverse transcription
Total RNA from the cell lines was extracted using Trizol
reagent (Invitrogen, Carlsbad, CA) following the manufacturer’s
protocol. To maximize the yield of total RNA from small NPC
biopsy samples, the total RNA was extracted using the miRVana
PARIS kit (Ambion, Austin, TX) according to the manufacturer’s
protocol. Transcriptor High Fidelity cDNA Synthesis Kit (Roche
Diagnostics Co., Indianapolis, IN, USA), prepared according to
the manufacturer’s protocol, was used to synthesize cDNA.
Quantitative real-time PCR
For quantitative PCR (qPCR) analysis, cDNA were subjected to
amplification with SYBR Green PCR Kit (Applied Biosystems,
Foster City, CA, USA) using primers for neural precursor cell
expressed, developmentally down-regulated 9 (NEDD9) and
gamma-amino butyric acid B receptor 1 (GABBR1). Human 18s
rRNA as used as the endogenous control. The threshold cycle (Ct)
was determined in real time using an ABI PRISM 7700 Sequence
Detector (Applied Biosystems, Foster City, CA, USA), and relative
expression levels were analyzed using the 2-DDCt method 2.
Transcript quantification was performed in duplicate for each
sample.
Association and statistical analyses
The association analyses in this study were performed by PLINK
(available online at: http://pngu.mgh.harvard.edu/purcell/plink/)
[20]. Single SNP association analyses on allelic and genotypic
associations include determining the p value, odds ratio (OR), and
95% confidence interval (CI). The Hardy-Weinberg equilibrium
6p Genes Associated with NPC
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HWEp-value was.0.001 and MAFwas .0.01. Logistic regression
analyses introduced age and gender as covariates. Linkage
disequilibrium (LD) analysis was conducted using both PLINK
[20] and Haploview 4.2 [21]. The panel of SNPs was entered into
the Haploview software, and the individual haplotype frequency
was estimated by the expectation-maximization (EM) algorithm.
The haplotype structure was also analyzed by PLINK using the
three-SNP sliding window option. Multiple testing was performed
with 10,000 permutations and/or by Bonferroni correction.
LocusZoom was used to generate the association plot (http://csg.
sph.umich.edu/locuszoom/).
The detection of runs of homozygosity (ROH) analysis was done
by PLINK. The algorithm involves taking a window of SNPs and
sliding it across the region. The homozygosity is determined if the
window looks ‘‘homozygous’’ enough at each window position.
For each SNP, the proportion of ‘‘homozygous’’ windows that
overlaps that position is calculated. The default window size and
homozygous segment criteria were set to the following: 1,000 kb
length, 100 SNPs, 50 kb/SNP density, and 1,000 kb for the largest
gap [20].
The SPSS software standard version 13.0 (SPSS Inc., Chicago,
IL) was used to perform the non-parametric t-tests, x2 tests, and
logistic regression tests to analyze the real-time PCR results
quantitatively.
Results
Genetic association study of 6p SNPs in southern Chinese
A genetic association study was performed on 360 NPC cases
and 360 controls patients recruited of southern Chinese descent.
For the 233 tag SNPs genotyped in this study, all followed the
HWE in either the case or control group with MAF $0.05 (allelic
association in Table S1). The overall genotyping call rate was
$97.8%. Two markers (rs235158 and rs1997716) showed a very
low informative rate (missing genotype .50%) and so were
excluded from data analysis. Figure 1 shows the genotyped SNPs
arranged according to their physical locations on Chr6 with allelic
associations (2log10 p-values). The most significant association was
found for SNP rs2076483 (p=3.36610
25). Two adjacent SNPs,
rs2267633 (p=4.49610
25) and rs29230 (p=1.43610
24), located
at the 6p23.31 region also showed high significance, suggesting
that this region was significantly associated with NPC (Figure 1).
The logistic regression test adjusted by age and sex did not change
the associations. After correcting for multiple testing (Bonferroni
correction), there were still significant associations for these three
SNPs. The p-values were 0.0004 for rs2076483, 0.0005 for
rs2267633, and 0.0017 for rs29230.
We noticed that the three most significant SNPs mapped to
6p23.31 region and were located within GABBR1, HLA-A, and
HCG9. It was only last year that the Taiwan GWAS study reported
these genes to be associated with NPC risk Thus, we were
surprised that we could also detect the association with high
significance by using only 360 patients/360 controls. This suggests
that loci within the 6p23.31 region, and particularly GABBR1 and
HLA-A alleles confer high disease susceptibility. Further research
on relevant functional genes and genetic replication in different
populations should be conducted using a large dataset.
Haplotype analysis of the GABBR1 and HLA-A gene
regions
This study involved over 200 SNPs located over a large region
of 6p; thus, the pair-wise linkage disequilibrium (LD) analysis that
was employed focused only on the regions and genes with high
significance. Haplotype structure was analyzed using the Haplo-
view software, and haplotype blocks were defined through
confidence intervals (default). The most significantly associated
haplotypes (AAA, p=6.46610
25 and GGG, p=1.0610
24,
respectively) were located within GABBR1 and comprised three
significant SNPs, rs2267633, rs2076483, and rs29230. Haplotype
AAA of GABBR1 was present more frequently in the sample cases
Figure 1. Single SNP allelic association analyses. The upper panel is the 2log10 p-value plotted against the genomic location (LocusZoom),
while the lower panel is the plotted single nucleotide polymorphisms (SNPs) of the studied region on chromosome 6p. Genes altered by micro-
deletion(s) are depicted according to their physical locations and translation directions.
doi:10.1371/journal.pone.0014562.g001
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0.733, respectively) and had a highly significant p-value of
6.46610
25. This indicates that individuals carrying the AAA
haplotype would be more susceptible to NPC than GGG carriers.
In contrast, the haplotype GG composed of rs2517713 and
rs2975042 within the HLA-A gene showed a protective effect
against NPC (p=7.0610
24; case and control frequency distribu-
tions of 0.279 and 0.363), whereas the haplotype TT exhibited
high risk for NPC disease (TT, p=0.0014; case and control
frequency distributions of 0.712 and 0.633). Multiple testing
correction was conducted with 10,000 permutations; haplotypes
AAA (p=0.0008) and GGG (p=0.0010) of GABBR1 and
haplotypes GG (p=0.0072) and TT (p=0.0134) of HLA-A all
survived the multiple testing.
We then confirmed these findings by PLINK haplotype-
association analysis. PLINK sliding window specification can
determine haplotypes in the sliding windows of a fixed number of
SNPs (shifting one SNP at a time) to form haplotypes across the
entire dataset [20]. In 3-SNP sliding windows, haplotypes AAA
and GGG formed by significant SNPs (rs2267633, rs2076483, and
rs29230) reached statistical significance (p=7.610610
25 and
p=7.614610
25 respectively). Two SNPs haplotypes formed by
rs2517713 and rs2975042 were GG and TT, with p-values of
0.00078 and 0.00078 respectively, which were even more
significant than Haploview results. Hence, haplotypic associations
supported the single SNP association results and indicated the
involvement of susceptibility genes in disease development.
LOH and micro-deletions at 6p as detected by SNP
genotyping
The high resolution of the SNP array and the large sample size
enabled us to monitor the small DNA copy number changes
occurring in NPC. In this study, the frequencies of homozygous
genotypes were compared with those of heterozygous genotypes
between NPC cases and matched healthy controls to detect
frequent LOH loci at 6p, as performed in our previous study [22].
To identify the micro-deletions at 6p in NPC, the frequency of the
homozygous genotype in the healthy controls and cases should be
determined first. For each SNP marker, the ratio of homozygous
frequency between the case and the control was calculated (T/N
ratio). Using a threshold T/N ratio .1.0, 19 loci that reached
statistical significance were considered frequent LOH loci. The
micro-deleted region was defined when 3 or more adjacent SNP
markers were considered frequent LOH loci. In this study, 3
micro-deletions were identified at 6p25-24, 6p21.31, and 6p21.3
(Table 1).
The presence of the extended homozygosity regions in human
genome can influence the accuracy of SNP genotyping. These
regions of homozygosity (ROHs) are characterized by multiple
contiguous homozygous SNPs, with size ranging from 200 kb to
more than 15 Mb [23,24,25]. To exclude interference by ROHs,
we employed PLINK to screen for runs of homozygous genotypes.
PLINK analyses showed that no ROH was detected across the
studied region (chr6: 6,095,364–30,048,467). Genes located within
the micro-deleted regions were then analyzed. The small deletions
on 6p affected several genes, including Glucosaminyl (N-acetyl)
transferase 2, I-branching enzyme (GCNT2), (NEDD9), and
GABBR1 (Table 1). The genes at 6p21.3 are pseudogenes, and
thus they were not considered for further study. The GCNT2 gene
has never been linked to cancer development, so we selected
NEDD9 and GABBR1 as the most promising potential candidate
genes. We examined their mRNA expression levels in different cell
lines and tissues.
Examination of mRNA expression of candidate NPC
susceptibility genes
To study the two candidate genes for the development of NPC,
mRNA expression was characterized by quantitative real-time
PCR in 3 NPC cell lines, CNE2, SUNE1, and C666-1, in the
immortalized normal nasopharyngeal epithelial cell line NP69,
and in 11 primary NPC tissue samples with adjacent normal tissue.
Compared with the normal nasopharyngeal epithelial cell line
NP69, SUNE1 and C666-1 cells demonstrated lower NEDD9
mRNA expression. Conversely, the CNE2 cell line displayed an
estimated 4-fold increase in NEDD9 expression (Figure 2A).
Compared with adjacent non-tumor tissue, 10 of 11 NPC tumor
biopsy samples showed a significant down-regulation of NEDD9
(P=0.015; Figures 2B and 2C). Moreover, GABBR1 was down-
regulated in all three NPC cell lines (Figure 2D) and in 8/11 tumor
biopsy tissues compared with the non-tumor tissue (Figures 2E and
2F). Statistically, the GABBR1 gene showed a marginally
significant association between the NPC tumor and non-tumor
tissue specimens (P=0.059). However, only 11 biopsy tissue
samples were available. Confirmation of a link between the
GABBR1 gene and NPC will require larger sample sizes.
Discussion
We demonstrated that multiple loci within 6p21.3 were
associated with NPC susceptibility. This study used sample sets
from southern China from which we found significant allelic and
haplotype associations with NPC. Compared with the genome-
wide association studies (GWASs) that examine large sample sets
and thousands of genetic markers, the case-control analysis is often
considered a necessary replication of GWAS findings. In this
Table 1. Summary of frequent LOH loci at 6p detected by
SNP-array.
SNP ID* Location T/N ratio
1 P value Gene name
rs2085575 6p25.3-24.3 1.2073538 0.004 F13A1
rs3024317 6p25.3-24.3 1.1449631 0.0181 F13A1
rs4960294 6p25 1.1457735 0.0298 RREB1
rs6597256 6p25 1.1318706 0.017 RREB1
rs267184 6p24-23 1.1431448 0.0253 BMP6
rs504083 6p24.2 1.1581754 0.0281 GCNT2
rs1318748 6p24.2 1.1529571 0.0371 GCNT2
rs11759513 6p25-24 1.1893557 0.0232 NEDD9
rs2137873 6p23 1.1861716 0.011 ATXN1
rs235147 6p23 1.1638418 0.03 ATXN1
rs236949 6p23 1.1905564 0.0047 ATXN1
rs2143083 6p22.3-22.2 1.3092179 0.0001 ALDH5A1
rs2267633 6p21.31 1.1809524 0.0033 GABBR1
rs2076483 6p21.31 1.2159952 0.0007 GABBR1
rs29230 6p21.31 1.1642882 0.0007 GABBR1
rs2517713 6p21.3 1.1925186 0.0109 HCP5P3
rs9260734 6p21.3 1.2099734 0.0033 HCG2P6
rs3869062 6p21.3 1.1733857 0.0101 HCG2P6
rs5009448 6p21.3 1.1841842 0.0164 MICD
1T/N ratio = homozygous frequency ratio of cases/control.
* SNP markers at micro-deleted region in bold.
doi:10.1371/journal.pone.0014562.t001
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HLA-A region was significantly associated with NPC. We also
found that the most significant SNPs were similar to those found in
a Taiwanese GWAS [10]. However, unlike the results of this
GWAS, the association in this study was at a SNP (rs2076483)
adjacent to that isolated in the Taiwan group (rs29230), but within
the same gene, of GABBR1. The subjects analyzed were all
southern Chinese and the MAFs were similar; thus, such deviation
might be due to genetic heterogeneity. None-the-less, that finding
that both associated SNPs were within GABBR1underscores a
possible role in the etiology of NPC.
Aside from genetic association, we further analyzed the SNP
genotyping data to identify the micro-deleted regions at 6p (6p25-
24, 6p21.31, and 6p21.3). Although SNP arrays are powerful tools
for the identification of chromosomal aberrations, especially
deletions or amplifications [26], there are several limitations to
this approach. One technical limitation is that SNP assays are
optimized for allelic discrimination rather than for copy number
measurement. Another potential drawback is the presence of
ROH, which could influence the accuracy of SNP genotyping. As
all the tag SNPs were derived from the HapMap dataset, there is
no clear indication of the existence of ROH across the studied
region; likewise, the PLINK ROH analysis showed the absence of
ROH within this region. Hence, it was possible to use SNP
genotyping data to detect micro-deletions within the region of
interest.
Two candidate genes located within the micro-deleted regions,
NEDD9 at 6p25-24 and GABBR1 at 6p21.31, were absent or
down-regulated at the mRNA expression level in primary NPC
tumors and NPC cell lines. Although the sample size (comprising
only 11 tumor samples) used for quantitative real-time PCR
analysis was not sufficient for statistical calculation, the qPCR
results did show alterations in gene expression levels. Here, the
different expression changes were from the copy number
variations in the tumor DNA and there was no direct link to the
micro-deletion detected when we compared normal DNAs
between cases and controls. However, the different expression
levels of NEDD9 and GABBR1 between PNC tumors and normal
tissues suggested the importance of both genes in PNC
development. A population-based study to determine if micro-
deletion in normal DNAs can also reduce GABBR1 expression is
clearly warranted.
The NEDD9 gene, also known as HEF1 and CAS-L, encodes a
scaffolding protein that promotes tumor cell migration and
invasion, but at the same time inducing apoptosis and mitotic
defects that trigger cell cycle arrest [26,27,28]. The NEDD9
protein product is subject to dynamic and complex regulation
[29]. Indeed, TGF-b [30], retinoic acid [31], and progesterone
receptor A [32] have all been reported to up-regulate the NEDD9
transcription, whiles estrogen down-regulated NEDD9 mRNA in
osteosarcoma [33] and breast cancer cells [34]. This study
provides the first evidence that the NEDD9 gene is subject
down-regulation at the transcriptional level due to copy number
loss in NPC tumors.
The GABBR1 gene was mapped to chromosome 6p21.31 within
the HLA class I region that also contains susceptibility loci for
multiple sclerosis, epilepsy, and schizophrenia. As a receptor
component of the inhibitory GABAergic system that transduces
GABA release into metabotropic signal transduction cascades, the
up-regulation of GABBR1 may have a suppressive effect on the
behavior of malignant tumors in NPC cancer cells [35]. A recent
study by Schuller et al. (2008) [36] demonstrated that GABBR1
could inhibit beta-adrenoreceptors (b-AR) signaling in pancreatic
cancer cells, thus blocking the driving forces of cancer progression
such as cell proliferation and cell migration; this indicates the
unexpected involvement of GABBR1 in cancer genesis.
The Taiwan GWAS was the first study to associate GABBR1
with NPC and found elevated GABBR1 protein expression in NPC
tumor tissues compared with the adjacent normal epithelial cells
[10]. Interestingly, when the GABBR1 transcript and protein levels
Figure 2. Expression of NEDD9 (A–C) and GABBR1 (D–F) at the transcription level. A and D are the real-time PCR results of NEDD9 and/or
GABBR1 expressions in cell lines. Immortalized NP cell line NP69 was used as a control for gene expression in normal NP tissues. B and E are the
boxplot diagrams of NEDD9 and/or GABBR1 expressions in 11 NPC tumor tissues and the adjacent non-tumor tissue. The difference in values was
based on real-time PCR analysis normalized to endogenous 18s expression. C and F are the real-time PCR analyses of 11 pairs of NPC biopsy
specimens. The changes in the NEDD9 and/or GABBR1 transcript expressions in each tumor specimen were compared against adjacent non-tumor
tissues. P represents the paired t-test p-value.
doi:10.1371/journal.pone.0014562.g002
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protein in two NPC cell lines, BM1 and HK1 (AA genotype at
rs29232), was observed compared with the immortalized naso-
pharyngeal epithelial cell line NP69 (AG genotype at rs29232).
The risk allele of rs29232 was ‘‘A,’’ and thus the homozygous
carrier of A-allele showed a lower protein level than the
heterozygous carrier. However, the study did not compare the
GABBR1 transcript and protein expression levels between normal
and cancer cell lines. Thus, the relationship between A-allele-
carrier and gene expression levels remains unknown. In this study,
we reported the down-regulation of GABBR1 transcripts in NPC
tumors, indicating that down-regulation of gene expression might
be one of the tumorigenic mechanisms. Given the importance of
GABBR1 involvement in NPC, its expression at the transcriptional
and protein levels requires further research.
In the course of this study, another GWAS, which was
conducted by a group from Guangzhou [12], was made available
online. Bei et al. (2010) validated the strong associations within the
HLA regions on 6p. In addition, they detected 3 new NPC
susceptibility loci on 3q26, 9p21, and 13q12 and identified novel
risk genes (TNFRSF19, MDS1-EVI1, and CDKN2A-CDKN2B gene
clusters) [12]. Their analyses showed that other candidate genes
and cancer genesis mechanisms could underlie the NPC
pathogenic process. In view of the high prevalence of NPC in
the southern China population, future study on NPC should focus
on novel pathogenic loci to discover new tumorigenic gene and
provide clinical targets for treatment.
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